News
March 16, 2019

According to a recent study of Clinical and Experimental Rheumatology, Tocilizumab (TCZ), an interleukin-6 receptor antagonist, found to have good cardiovascular safety as it significantly regulates the adiponectin and chemerin serum levels, without affecting treatment response among rheumatoid arthritis (RA) patients. Adipokines have an essential part in rheumatoid arthritis pathophysiology and present a connection between the disease and overweight.

7min read    
News
March 14, 2019

As the evaluation of disease activity in obese rheumatoid arthritis (RA) patients is challenging, a study was recently carried out to examine the measures set by the American College of Rheumatology (ACR) used in assessing RA disease activity with the specific focus on the swollen joint count (SJC).

7min read    
News
March 12, 2019

Hybrid fixation technique restored partially salvageable osteochondritis dissecans (OCD) lesions of the knee presented positive short-term outcomes with low complication rates according to a retrospective study published in Journal, Cartilage. OCD is a frequently occurred problem that leads to knee pain functional instability.

7min read    
News
March 12, 2019

As per research published recently in the Arthritis Care & Research Journal, the patients who used statins for more than five years has considerably less risk of knee pain although their role in osteoarthritis (OA) management is still debatable. Statins, HMG-CoA reductase inhibitors show various pleiotropic impacts, but their relationship with regards to knee osteoarthritis is inadequate.

7min read    
News
March 11, 2019

According to recent research carried out by the doctors of Bichat Hospital Paris Diderot University France, Anakinra, a recombinant, nonglycosylated human interleukin-1 receptor antagonist was significantly helpful in treating acute calcium pyrophosphate (CPP) crystal arthritis among patients who were unable to respond conventional therapies.

7min read